Specialist Nurse-Led Cross-Linking Service For Keratoconus, The Leeds Experience
Published 2022 - 40th Congress of the ESCRS
Reference: PPE28.01 | Type: ESONT - Abstract | DOI: 10.82333/jtna-t054
Authors: Rita Prajapati, Alan Salada 1 , Arthur Arthur Okonkwo 1 , Numan Sarfraz* 1 , Andrew Morrell 1 , Ahmed Bardan 1 , David Dunleavy 1 , Seema Anand 1
1St James Hospital Leeds,Leeds,United Kingdom
Purpose
Setting/Venue
Methods
Results
186 out of 190 patients underwent CXL for keratoconus. Of the 186 patients, 179 (96.2%) did not demonstrate any evidence of progression following cross-linking. There was a mean improvement in best corrected visual acuity (BCVA) of 0.6 lines with 69 (46.3%) of these patients demonstrating an objective improvement. There was no documented change in vision in 57 (38.3%) patients. There were no episodes of microbial keratitis or any other adverse events following nurse-led CXL.
Conclusions
Results have shown successful implantation of a safe and effective nurse-led CXL service, allowing for increased departmental capacity and flexibility and reduced patient waiting times. Furthermore, senior clinicians have been freed up and surgical capacity increased to target more complex cases.